SFRP2 and cyclic hematopoiesis: Our results demonstrate that both promoters of Wnt inhibitor genes (SFRP2 & DKK1) experience a significantly elevated levels of DNA methylation in HCV infected non-cancerous disease cohorts (CH & LC) as well as HCC patients as compared to normal controls.